There's new evidence that depression is not just a disorder of the mind.
Verified by Psychology Today
From quirky to serious, trends in psychology and psychiatry
Christopher Lane Ph.D.
A large new study finds an increased risk of unexpected deaths in patients aged 5 to 24 who received antipsychotics.
A new survey of withdrawal from psychiatric drugs points to symptoms that are often incapacitating but poorly understood by those prescribing.
A major new study finds that antidepressant withdrawal is much more widespread, chronic, and longer-lasting than national guidelines suggest.
New research warns that self-diagnosing apps are unreliable and encourage overtreatment.
With child and teen anxiety on the rise, new research shows that preferred treatments often have poor long-term outcomes.
Our well-being and that of our neighbors is more interlinked than we realize.
New research documents just how forcefully social media algorithms are driving polarization.
A new report on the closed loops of disinformation stoking chaos and confusion.
In the U.S. and other developed countries, there are now clear signs that child and adolescent mental disorders are overdiagnosed.
The U.S. shows growing signs of being an unhappy, divided country, according to a string of indexes measuring national happiness and well-being.
The expanding influence of genomics on our lives.
On the parallels between Trumpism and other mass movements.
On rereading “The Authoritarian Personality” in 2017.
What the feeling of dislocation can teach us about these unsettling times.
In the battle against opioid addiction, court-released documents show drug makers deliberately blocked efforts to curb prescribing.
How did we reach the point where one in seven American children is diagnosed with ADHD?
Selective reporting and inflated effect sizes mar even high-impact studies in the neurosciences, according to two weighty new analyses.
The latest meta-analysis will intensify concern that antidepressants are ineffective and harmful.
A stress on anticipated harmony and positivity is part of the problem.
The average American TV viewer is exposed to up to 30 hours of prescription drug ads each year. Enough already.
According to two new studies, outcome switching in clinical trials is widespread.
As income inequality rises, the well-being gap in most countries widens.
Almost half the country reports significant, recurring discrimination tied to race and ethnicity.
Adderall misuse among college and high school students increasingly is seen as unexceptional.
On the "ethical perils" facing a branch of medicine now greatly beholden to its industry sponsors.
One of the most influential psychiatrists of the twentieth century leaves a complex legacy.
Neuropolitics is going global. To what end? At what cost?
Why is the placebo effect intensifying among Americans—and why now?
Ghostwriters, massaged data, tiny print, and children’s toys—part of Big Pharma's arsenal of "defeat devices," outlined in Steven Brill's series, America's Most Admired Lawbreaker.
A major new study about a blockbuster antidepressant.
Christopher Lane, Ph.D., has won a Prescrire Prize for Medical Writing and teaches at Northwestern University. He is the author of Shyness: How Normal Behavior Became a Sickness.